Use of C-Reactive Protein and Ferritin Biomarkers in Daily Pediatric Practice

Matthew D Taylor1, Vivek Allada2, Michael L Moritz3

  • 1Division of Critical Care Medicine, Cohen Children's Medical Center of New York, New Hyde Park, NY.

Pediatrics in Review
|April 3, 2020
PubMed

Insights

Pediatricians can use C-reactive protein (CRP) and ferritin biomarkers to assess inflammation. While useful in specific scenarios, further research is needed to standardize their application in clinical practice.

Area of Science:

  • Pediatric Clinical Research
  • Biomarker Analysis
  • Inflammation Studies

Background:

  • Multibiomarker models are increasingly used for risk stratification in pediatric clinical research.
  • C-reactive protein (CRP) and ferritin are widely available biomarkers in pediatric practice.
  • A comprehensive review of evidence supporting CRP and ferritin use in pediatrics is lacking.

Purpose of the Study:

  • To summarize existing evidence on the use of CRP and ferritin biomarkers in pediatric practice.
  • To initiate the development of a consensus for the future application of these biomarkers by pediatricians.
  • To provide a single-source resource for clinicians regarding these inflammatory markers.

Main Methods:

  • A systematic survey of all pediatric literature on CRP and ferritin available in PubMed was conducted.
  • Research relevant to daily pediatric clinical practice was summarized.
  • Contributions from pediatric subspecialists were integrated to describe biomarker use across various disease processes.

Main Results:

  • CRP and ferritin biomarkers exhibit diverse applications and varied cutoff values in the literature, complicating daily clinical use.
  • Elevated levels of CRP and ferritin correlate significantly with uncontrolled inflammation.
  • A clinical decision pathway and summarized evidence are presented.

Conclusions:

  • CRP and ferritin are widely utilized biomarkers in pediatrics.
  • Sufficient evidence supports the utility of these inflammatory biomarkers in guiding clinical decisions in specific pediatric cases.
  • Further research and standardization efforts are necessary to optimize the use of CRP and ferritin in routine pediatric clinical practice.

Related Concept Videos

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
454
Drug Dosing in Renal Diseases: Measurement of Serum Creatinine Concentration and Clearance01:25

Drug Dosing in Renal Diseases: Measurement of Serum Creatinine Concentration and Clearance

In healthy individuals, serum creatinine levels remain stable due to a balance between its constant production—primarily from muscle metabolism—and renal excretion. Creatinine is freely filtered by the glomeruli, making it a valuable marker for estimating renal function. When the glomerular filtration rate (GFR) decreases, the kidneys can only eliminate less creatinine, causing serum levels to rise.Serum creatinine concentration is widely used to estimate creatinine clearance...
123
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
702
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
123
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
150